Refinitiv, previously known as Thomson Reuters, has released their Global League Tables for Q3 2023, and Benchmark International was recognized with several high rankings in multiple categories. Also of note, for the year-over-year change in the number of deals both in the U.S. and Worldwide, Benchmark International is nearly the only firm to show a positive change in the number of deals.READ MORE >>
Benchmark International is a finalist for an impressive 22 awards in the 22nd Annual M&A Advisor Awards. Our transactions and firm were among hundreds of entries from 450 participating companies that have successfully passed the initial evaluation stage. The process will continue as the independent panel of judges further evaluates and selects a winner from the finalists in each category. The judges are peers in the mergers and acquisitions transaction space, and it is quite an accomplishment to be recognized thus far as a finalist.READ MORE >>
Correctly calculating adjusted EBITDA is essential in an M&A transaction, and all parties must be familiar with the adjustments. EBITDA is used to evaluate a company’s profitability of its core operations by removing items dependent on capital structure, such as interest,READ MORE >>
In M&A transactions, many sellers often think the hard work is over as soon as they have found the right buyer and gotten the offer of their dreams. Experienced dealmakers recognize this as the start of the hard work in the process rather than the finish line. After an agreed-upon offer, there is a full due diligence process wherein the purchaser will review the entire historical performance, tracking, and operations of the business to be bought, which in and of itself can be a monumental task even before any financial audit or legal proceedings begin. This process is typically managed to utilize a universally accessible location for files, along with a master checklist of which items are where to assist in making the process more fluid.READ MORE >>
Benchmark is pleased to announce the transaction between Asolva, Inc, and Harris Computer Systems, a Constellation Software Inc portfolio company. The transaction creates a strategic product expansion for their existing Healthcare companies.